PATIENCE DAVID (Chief Financial Officer) purchased 2.6% of their position (7.10K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $17.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/18/2026ACC: 0001628280-26-035992
Officer· Chief Financial Officer
Since Feb 2026
+7.10K
Net shares
Net buyer
$17.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
7.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.10K
Price / share
$2.43
Trade value
$17.25K
% of position
2.6%
5/15/2026
268.66K→275.76K
Total
Net shares
+7.10K
Net value
$17.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | P · Purchase | +7.10K | $2.43 | $17.25K | 2.6% | 268.66K | 275.76K |
| Total | +7.10K | $17.25K | ||||||
Derivative Transactions0
No derivative transactions reported